| ALK-G1269A mutation in epithelioid inflammatory myofibroblastic sarcoma after progression on crizotinib: A case report | |
| Xu, Xiaojing; Li, Hong; Peng, Ke; Yu, Yiyi; Chen, Lingli; Fang, Yong; Sun, Yihong; Hou, Yingyong; Liu, Tianshu | |
| 刊名 | ONCOLOGY LETTERS
 |
| 2019 | |
| 卷号 | 17期号:2 |
| 关键词 | epithelioid inflammatory myofibroblastic sarcoma anaplastic lymphoma kinase kinase inhibitor crizotinib Brigatinib drug resistance |
| ISSN号 | 1792-1074 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3595737 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Xu, Xiaojing,Li, Hong,Peng, Ke,et al. ALK-G1269A mutation in epithelioid inflammatory myofibroblastic sarcoma after progression on crizotinib: A case report[J]. ONCOLOGY LETTERS,2019,17(2). |
| APA | Xu, Xiaojing.,Li, Hong.,Peng, Ke.,Yu, Yiyi.,Chen, Lingli.,...&Liu, Tianshu.(2019).ALK-G1269A mutation in epithelioid inflammatory myofibroblastic sarcoma after progression on crizotinib: A case report.ONCOLOGY LETTERS,17(2). |
| MLA | Xu, Xiaojing,et al."ALK-G1269A mutation in epithelioid inflammatory myofibroblastic sarcoma after progression on crizotinib: A case report".ONCOLOGY LETTERS 17.2(2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论